Taxol, a fairly new chemotherapeutic agent also known as paclitaxel, is used in the treatment of ovarian and lung cancer.
Angiotech is a Canadian company which is developing methods of delivery of anti-angiogenesis products. Angitech found taxol to be the most potent angiogenic inhibitor that they have tested.
Although:
The occurrence of life-threatening events was found to be uncommon among 107 patients with taxol administered at a high dose of 250 mg/m2. Taxol with G-CSF was considered to be a well-tolerated regimen. Higher doses of taxol were held to be associated with higher disease response rates.
Taxol is dangerous:
Taxol-induced neuropathy is dose dependent with higher dose per cycle and total dose and is at least partially reversible.
and
A total of 11 cases have been identified of colonic perforation following taxol therapy, an infrequent result but which can have a high mortality rate.
For information regarding alternative cancer treatmnets, visit the Alternative Cancer Treatments Comparison.
For more information on ovarian cancer and the sources of the above information.
Visit Protocel and Protocel.us
Carpal Tunnel Syndrome (CTS) Relief